The UK Review on AMR releases its final conclusions (June 25th 2016)
The UK Review on Anti-Microbial Resistance headed by Jim O’Neil
READ MOREThe UK Review on Anti-Microbial Resistance headed by Jim O’Neil
READ MOREThe Beam Alliance is an association of about 50 European SMEs involved in the development of antibiotics, antimicrobials and alternative approaches. Its objective is to give a voice to the SMEs, pivotal actors of the value chain of Antibiotics R&D. Drive-AB is a IMI project part of the New Drugs For Bad Bugs (ND4BB) umbrella whose objectives is to suggest new economic models tailored to rejuvenate the antibiotics R&D pipeline. It ambitioned to gather all relevant stakeholders but the SMEs had been overlooked. With the addition of BEAM all the […]
READ MOREPublic Symposium on Novel viral and cellular targets against HIV
READ MOREThe newly launched Alliance of Biotechs of Europe innovating in Anti-Microbial Resistance.
READ MOREConference on Retrovirus and Opportunistic Infections.
READ MORE€4 million to Mutabilis for its project on HIV.
READ MOREThe global competitiveness cluster specializing in innovative technologies for health and new therapies.
READ MORE